Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between the ages of 45 and 65 years old
- People with a body mass index (a measure of body weight relative to height) between 30 and 50
- People who weigh at least 110 pounds
- People who currently do 60 minutes or less of moderate-to-vigorous physical activity per week, based on a short questionnaire at screening
- People who own a smartphone that runs iOS (Apple) or Android software, as this is needed to track activity using a Fitbit device provided by the trial
Who may not be able to join:
- People who answer "yes" to any question on a standard physical activity health-readiness questionnaire, unless a doctor's note is provided
- People whose resting blood pressure is higher than 200/110 mmHg at their first study visit, unless a doctor's note is provided
- People who are pregnant or planning to become pregnant within the next 8 months (Phase 1) or 12 months (Phase 2)
- People who plan to move away from the metropolitan Phoenix, Arizona area within the next 8 months (Phase 1) or 12 months (Phase 2)
- People who are currently enrolled in, or plan to join, another physical activity, nutrition, or weight loss program during the study period
- People who have been diagnosed with mild cognitive impairment (a condition affecting memory and thinking), or who score below a certain threshold on a memory and thinking test given at the study orientation session (confirm with trial site for exact score thresholds, which vary based on country of birth and language of schooling)
- People who have previously been prescribed any of the following Alzheimer's medications: Donepezil (Aricept), Rivastigmine (Exelon), Galantamine (Razadyne), Memantine (Namenda), or a combination of Memantine and Donepezil (Namzaric)
- People who score 16 or higher on a standard depression symptom questionnaire (the CES-D scale)
- People who have a current self-reported diagnosis of major depression
- People who are currently taking two or more antidepressant medications
- People who have had a stroke at any point in the past
- People who are currently incarcerated
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 602-496-0772
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in accelerometer-measured moderate-to-vigorous intensity physical activity from baseline to 6- and 9-months; Change in Fitbit-assessed moderate-to-vigorous intensity physical activity; Change in self-reported moderate-to-vigorous intensity physical activity from baseline to 6- and 9-months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.